Iohexol
Iohexol is a pharmaceutical drug with 41 clinical trials. Currently 4 active trials ongoing. Historical success rate of 89.3%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
2
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.1%
25 of 32 finished
21.9%
7 ended early
4
trials recruiting
41
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
A Study of LY4515100 in Healthy Participants
Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
Fluorescent Probe for Assessment of Renal Elimination
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
Clinical Trials (41)
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
A Study of LY4515100 in Healthy Participants
Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
Fluorescent Probe for Assessment of Renal Elimination
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block
Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance
Low-acid Contrast Media for Preventing Post ERCP Pancreatitis
Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
Virtual Colonoscopy Using Omnipaque as a Contrast Agent
Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans
Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function
Development of a Bayesian Estimator for Calculating Plasma Iohexol Clearance
Method VALIDation and Evaluation of Non-radioactive Methods to Measure Glomerular Filtration Rate
Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
A Study of Effect of LY3556050 on Metformin in Healthy Participants
A Study of LY3526318 in Healthy Male Japanese Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 41